market forecast
Jan 08, 2018
Hereditary Angioedema (HAE) – Active drug pipeline
Hereditary Angioedema (HAE) is an autosomal dominant disease which is caused by a deficiency in functional C1 inhibitor. It is a rare hereditary disease which is characterized by painful, unpredictable, recurrent attacks of inflammation and swelling affecting the hands, feet, face, abdomen, urogenital tract, and the...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
